youtube_live
Q1 2027 earnings • released • EPS beat +8.86% • Revenue beat +1.55%
See resultschevron_right
RMD:NYSE
Resmed Inc
$232.94
arrow_upward
+1.30%(+3.00) 1D
$232.94
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 2, 4:00:04 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RMD...
Open
$231.27
High
$233.76
Low
$227.73
Mkt. cap
32.76B
Avg. vol.
1.17M
Volume
1.60M
Dividend
1.13%
Quarterly dividend
$0.66
Ex-dividend date
Aug 20, 2026
P/E ratio
21.22
52-wk high
$277.67
52-wk low
$180.26
EPS
$10.98
Beta
0.75
Shares outstanding
140.64M
No. of employees
11K
Open
$231.27
High
$233.76
Low
$227.73
Mkt. cap
32.76B
Avg. vol.
1.17M
Volume
1.60M
Dividend
1.13%
Quarterly dividend
$0.66
Ex-dividend date
Aug 20, 2026
P/E ratio
21.22
52-wk high
$277.67
52-wk low
$180.26
EPS
$10.98
Beta
0.75
Shares outstanding
140.64M
No. of employees
11K
News stories
From web sources and news partners
marketscreener.com
·
11 hours ago
ResMed Likely Able to Sustain Earnings Growth, UBS Says
TheBull.com.au
·
12 hours ago
ResMed Shares Dip On Earnings, Bullish Analyst Shifts Neutral
MedTech Dive
·
13 hours ago
AdvaMed Chair Mick Farrell shares his top priorities, challenges for the medtech industry
Yahoo Finance
·
20 hours ago
ResMed: 3 Key Takeaways for Long-Term Investors
Profile
Resmed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers.
Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024. Wikipedia
About Resmed Inc
CEOMichael J. Farrell
Employees11.4K
FoundedJun 1989
HeadquartersSan Diego, California, United States
SectorMedical device
Websiteresmed.com